Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.
Up 10.26%.
Miavoce.
"Emerald, the cancer doesn't need to have spread for CTC analysis to be relevant. All solid tumours release CTC's irrespective of metastatic status.".
=========================
Very interesting. Thanks. You mean if you have cancer that has NOT spread you may have circulating tumour cells in your blood stream? Not good. Did not know that. Means analysis is possible even when the cancer has NOT spread then.
All IMHO.
Up 7.69%.
They may have arrived !
Hello.
In view of the contracts with both Eisai and now Astrazeneca I'm half expecting Angle to gain another major investor i.e. an investment house building up a stake of several percent. The Eisai contract news on the 2nd of Jan was a relatively small contract. That clearly was insufficient to get another major player on board. However, the RNS of 3rd May, a half million £ contract with Astrazeneca, I think will. It's now completely obvious that both these Companies realise monitoring the circulating tumour cells is necessary when conducting a cancer drug trial involving ANY cancer that has metastasised (spread). The market is absolutely MASSIVE. Could become the "Standard procedure" when doing a cancer drug trial involving a cancer that has spread. The implications are mind blowing.
https://www.lse.co.uk/rns/AGL/new-commercial-agreement-with-large-pharma-gvzk9wgh1la0ljx.html
https://www.proactiveinvestors.co.uk/companies/news/1046802/angle-announces-second-assay-with-astrazeneca-as-it-deepens-relationship-with-pharma-giant-1046802.html
All IMHO.
Market cap's OVER $15 billion is NOT going to make a bid for Angle Plc?
Angles market cap is just $61 Million (not Billion!).
Any offer would have to be more than the last placing price of ****80p**** a share I think.
Curent sp.......................20.5p ! JOKE!
All IMHO.
Catch and carry out tests on circulating tumour cells in patients with cancer that has matasicised (spread), right? Astrazeneca are ranked 7th in the World, and Eisai 49th largest right? The smallest of the two is Eisai with a market cap of $15 billion. Astras is $212 bilion. So there are ****48 Pharma Plc's with a market cap exceeding $15 billion****.................... This is a "NO BRAINER" if ever there was one. TWOGOOD...... DO YOU UNDERSTAND? Maybe not......
All IMHO.
And send the Pharma Co the results. Just pay them!
Join Eisai and Astrazeneca while they still have capacity.......! LOL!
Form an orderley queue........
Up 3.85%.
Roll up! Get your circulating tumour cells analysed at Angle Plc during your cancer drug trial. You need the information don't you! Mad not to!
And they will catch and analyse the circulating tumour cells in the blood and do whatever tests you want to see how your drug is performing. Simples!!! All you do is pay and get the resuts.
Get in quick while you still can!
Astrazeneca and Eisai are already in........
LOL!
All IMHO.
In the interview Andrew Newland states Angle are in discussions with SIX additional "household name" Pharma Co's at the moment. That is just at the moment. Eisai (the first large Pharma Co Angle have a contract with) are 49th in this list with a market cap or $15 billion. So, there are 49 Co's in the World with a larger market cap than $15 billion. This includes Astrazeneca in 7th (market cap $212 billion) that we know Angle currently have 2 contracts with.
***Angle have a massive potential WORLDWIDE market.**
This is TOTALLY OBVIOUS. The sp is daft low.
For the top 50 Pharma Co's see here:-
https://www.visualcapitalist.com/cp/worlds-50-largest-pharmaceutical-companies/
For the interview see here:-
https://www.proactiveinvestors.co.uk/companies/news/1046802/angle-announces-second-assay-with-astrazeneca-as-it-deepens-relationship-with-pharma-giant-1046802.html
List of biggest pharma Co's in the World.
Interestingly Astrazeneca are ranked 7th in the world and Eisai are 49th (Angle are now working with both).
So our CEO says he is in discussions with another 6 "household names". All of them must be on the list!
See here:-
https://www.visualcapitalist.com/cp/worlds-50-largest-pharmaceutical-companies/
Roche
Miavoce.
"Emerald - AN said that 6 (not 2) of the 11 pharma's they are talking to are household names.".
===================
Just checked and you are correct. 6 other "household names", not 2 as I posted.
My appologies.
Would be nice this week. They are taking to another 2 "household names". And another 9 less well known as Mr Newland said in the interview.
Ticked up......
With the recent fantastic news about the contracts with Astrazeneca and Eisai it seems to me any placing could be at a premium the current sp (assuming they don't want to wait up to another year or so to see how the finances are). More common that you might think. I bet you are very very worried?
All IMHO.
With the recent fantastic news about the contracts with Astrazeneca and Eisai it seems to me any placing could be at a premium the sp (assuming they don't want to wait up to another year or so to see how the finances are). More common that you might think. I bet you are very very worried.
All IMHO.
In Angle Plc!!!! LOL!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
No-one is going to believe that. I mean no-one.
I can't believe you posted that.
Another one of your lies no doubt.
Analysis via automated AI microscope. The need for clinicians to know the HER2 status of a person with Breast cancer is vital to decide on the most appropriate treatment. In the RNS Angle said this:-
"Given the significant third-party interest in a new assay for quantitative HER2 analysis based on CTCs, ANGLE and Bioview have agreed to allow for the inclusion of third parties in this project and its funding as we move into the commercialisation stage *****after the initial development work is complete*********. The parties are continuing to discuss strategic routes to market with potential corporate partners. ".
The initial development work is complete...............
More potential ££££ and this could be literally any day.
All IMHO.